Ellevest, Inc. Vir Biotechnology, Inc. Transaction History

Ellevest, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 18, 2022	BUY	$19.08 - $26.7 $419 - $587	22 New	22 $1,000
Q1 2022 Apr 19, 2022	SELL	$21.19 - $40.01 $105 - $200	-5 Closed	0 $0
Q4 2021 Jan 24, 2022	BUY	$30.97 - $54.03 $154 - $270	5 New	5 $0
Q3 2021 Oct 19, 2021	SELL	$34.9 - $54.54 $69 - $109	-2 Closed	0 $0
Q2 2021 Jul 13, 2021	BUY	$38.75 - $51.0 $77 - $102	2 New	2 $0

228

88.4M

571K

216K

Ticker VIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 132,638,000
Market Cap $1.28B
Description
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...

Get notified when there are updates to the investment portfolio of Ellevest, Inc., based on Form 13F filings with the SEC.

Stay updated on Ellevest, Inc. with notifications on news.